Providers identify 5 key areas for person-centered care of residents with dementia
By
Kimberly Bonvissuto
Nov 19, 2020
Several senior living companies were part of a roundtable that helped researchers identify five areas of change and developed person-centered practical solutions to address the unmet needs of people with...
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Aging Committee leaders cheer bipartisanship
By
Lois A. Bowers
Nov 30, 2016
As the ranking member of the Senate Special Committee on Aging prepares to depart from that role, she and the committee’s chairwoman celebrated what can be accomplished when Republicans and Democrats...
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
$625,000 stipend will continue work to alter perceptions of aging, dementia
By
Lois A. Bowers
Oct 05, 2016
Anne Basting’s work to improve older adults’ quality of life and change perceptions related to aging and dementia recently received a big boost in the form of a $625,000 “genius grant”...
FDA delays decision on new Alzheimer’s drug
Mar 08, 2024
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
Increased risk of Alzheimer’s in older adults with COVID a ‘scary prospect’ for senior living providers
By
Kimberly Bonvissuto
Sep 23, 2022
Older adults previously infected with COVID-19, especially women aged 85 or more years, show a substantially higher risk of developing Alzheimer’s disease within a year, according to the results of a...
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
Illinois first state to require dementia diagnosis training for healthcare professionals
By
Kimberly Bonvissuto
Aug 20, 2021
Illinois is the first state in the nation to require Alzheimer’s diagnosis training for healthcare professionals, officials said this week, thanks to a new law signed by Gov. JB Pritzker on Monday.